Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2026-02-28 @ 5:33 AM
Study NCT ID:
NCT05013268
Status:
UNKNOWN
Last Update Posted:
2021-08-24
First Post:
2021-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma
Sponsor:
Ruijin Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TiTanec
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None